Back to search

Article

Synergic Renoprotective Effects Of Combined ASC Therapy With RAAS Blockade In Experimental Advanced CKD

2021-09-20

Abstract excerpt

<h4>ABSTRACT</h4> Global prevalence of chronic kidney disease (CKD) has increased considerably in the recent decades. Overactivity of the renin-angiotensin-aldosterone system (RAAS), associated to renal inflammation and fibrosis contribute to its evolution. The treatments currently employed to control CKD progression are limited and mainly based on the pharmacological inhibition of RAAS, associated with diuretics...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
84a6b375-430b-5278-ac6b-570b8d82f39c
DOI
10.1101/2021.09.20.461095
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Synergic Renoprotective Effects Of Combined ASC Therapy With RAAS Blockade In Experimental Advanced CKDDOI 10.1101/2021.09.20.461095
Select a neighboring publication to make it the new centre.